Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians

Por Palumbo, Raffaella, Sottotetti, Federico, Riccardi, Alberto, Teragni, Cristina, Pozzi, Emma, Quaquarini, Erica, Tagliaferri, Barbara, Bernardo, Antonio
Publicado em 2013

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of...

Por Palumbo, Raffaella, Sottotetti, Federico, Trifirò, Giuseppe, Piazza, Elena, Ferzi, Antonella, Gambaro, Anna, Spinapolice, Elena Giulia, Pozzi, Emma, Tagliaferri, Barbara, Teragni, Cristina, Bernardo, Antonio
Publicado no Drug Des Devel Ther (2015)

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Ital...

Por Lambertini, Matteo, Ferreira, Arlindo R., Poggio, Francesca, Puglisi, Fabio, Bernardo, Antonio, Montemurro, Filippo, Poletto, Elena, Pozzi, Emma, Rossi, Valentina, Risi, Emanuela, Lai, Antonella, Zanardi, Elisa, Sini, Valentina, Ziliani, Serena, Minuti, Gabriele, Mura, Silvia, Grasso, Donatella, Fontana, Andrea, Del Mastro, Lucia
Publicado no Oncologist (2015)